Company

About

Cambrex

Cambrex

Charles City, Iowa, United States

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance development and manufacturing across the entire drug lifecycle, as well as comprehensive analytical and IND enabling services. With over 40 years of experience and a growing team of over 2,000 experts servicing global clients from North America and Europe, Cambrex is a trusted partner in branded and generic markets for API and finished dosage form development and manufacturing.

CartilaGen

CartilaGen

Iowa City, Iowa, United States

CartilaGen Inc. is developing an intra-articular injection of a small-molecule drug capable of preventing post-traumatic osteoarthritis. CartilaGen's solution aims to provide an unprecedented disease-modifying treatment to an area of medicine that remains an unmet medical need.

Emmyon

Emmyon

Coralville, Iowa, United States

Emmyon - Discovery and development of small molecules that improve muscle mass, strength and metabolism Commercialization of small molecules through licensing agreements and partnerships with consumer-facing companies Funded by private investors and the National Institutes of Health